I have no clue why this didn't post on Father's day as I set it to. I am marginally annoyed by that. Better late than never, I suppose... I've been writing for this blog for some time now (according to my last post anyway) so I know when it's time for a certain daddy blogger [...]
Malecare , via Malecare's Advanced Disease Program Director Joel Nowak , is the first to break the following news: Hot off the press- The U.S. Food and Drug Administration (FDA) has approved Sanofi-Aventis SA's new chemotherapy drug for advanced prostate cancer. The drug, Jevtana (cabazitaxe) extended by nearly 2-1/2 months the lives of men with [...]
Hot off the press- The U.S. Food and Drug Administration (FDA) has approved Sanofi-Aventis SA's new chemotherapy drug for advanced prostate cancer. The drug, Jevtana (cabazitaxe) extended by nearly 2-1/2 months the lives of men with prostate cancer tumors that resist standard treatment with hormones as well as chemotherapy. The drug will be used after [...]
The approval of Provenge has once again brought to the forefront the very important questions about the proper timing of treatments as well as the issue concerning how to combine therapies to maximize survival. We have, although there numbers are limited, different treatments that are used for the treatment of advanced prostate cancer, but we [...]
Did you hear the news? These alarming 2010 projections for prostate cancer deaths were just released. Isn't it nice that they were released just prior to Father’s Day, so have a happy Father’s Day. These projections call for a massive 17 % increase in prostate cancer caused deaths as well as a more than 13 [...]